All lobbying filings
WINNING STRATEGIES WASHINGTON
Lobbying for KALEO · Pharmaceutical development and manufacturing
Filing
3rd Quarter - Report
Reporting period
3rd Quarter 2025
July 1 - Sep 30 · Posted Oct 19, 2025
Income
$10,000.00
What the client paid this registrant for the period.
Client based in
Virginia
Lobbyists on this filing
3
-
ROBERT ZUCKERPreviously held: LD, Rep. Rothman; LA,Rep. Evans (IL); Sen. Lautenberg
-
CHELSEY PENROD HICKMANPreviously held: CoS, LD, Rep. Kay Granger; Deputy LD, LA Sen. Larry Craig
-
CHARLA PENNPreviously held: LA, Rep. Pascrell; SA/LC/LA, Rep. Boyd
Government bodies contacted
2
Lobbying activity
5
Legislation related to prescription drug prices, access to epinephrine in schools, childcare, and other community settings
Pharmaceutical drug development, including epinephrine for anaphylaxis; drug access and affordability issues
Medical countermeasures research and development
Medical countermeasures research and development
FAA reauthorization provisions related to emergency medicine.